Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segments
MarketWatch·2026-01-15 21:11公司股价表现 - Penumbra公司股票在交易于周四上午宣布后上涨约14% [1]
MarketWatch·2026-01-15 21:11 MarketWatch·2026-01-15 21:11 MarketWatch·2026-01-15 21:11公司股价表现 - Penumbra公司股票在交易于周四上午宣布后上涨约14% [1]